Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release

Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
International Journal of Pharmaceutics (Impact Factor: 3.79). 01/2007; 326(1-2):100-6. DOI: 10.1016/j.ijpharm.2006.07.010
Source: PubMed

ABSTRACT The aim of this study was to obtain a prolonged release of Vitamin A palmitate (RAP) and aciclovir from biodegradable microspheres for intraocular administration with an antiviral action and to be capable of preventing the inherent risks of intravitreal administration. The RAP effect on the microsphere characteristics was also studied. Poly(D,L-lactic-co-glycolic) acid microspheres were prepared by the solvent evaporation method. Different quantities of aciclovir (40-80 mg) and RAP (10-80 mg) were added to the internal phase of the emulsion. Microspheres were analysed by scanning electron microscopy, which revealed a spherical surface and a porous structure, and granulometric analysis that showed an adequate particle size for intraocular administration. The aciclovir loading efficiency increased when Vitamin A palmitate was added. Differential scanning calorimetry detected no differences in the polymer glass transition temperature and the aciclovir melting endotherm in all formulations. The release of aciclovir during the first days of the in vitro assay was improved with respect to microspheres without RAP. The microspheres showed a constant release of aciclovir and RAP for 49 days. Best results were obtained for microspheres prepared with 40 mg aciclovir, 80 mg RAP and 400mg polymer. A dose of 4.74 mg of microspheres would be therapeutic for the herpes simplex and Epstein-Barr viruses' treatment in an animal model and would reduce the intravitreal adverse effects. The injectability of a suspension of microspheres in isotonic saline solution resulted appropriate for its injection through a 27 G needle.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Awareness of the role that nutraceuticals play in the treatment and prevention of disease has led to an explosion of research in this exciting arena that seems to overflow into the food, cosmetic, nutraceutical, and pharmaceutical industries. Nutrients, supplements and herbal compounds have shown promise as either alternatives to modern medicine or complementary tools in the treatment and prevention of disease. This review provides a brief outlay of the advantages and challenges of nutraceutical delivery via dermatological, oral and ophthalmic routes. Emphasis is directed towards nutraceutical formulation strategies adopted to overcome physicochemical challenges and instability of natural bioactives in order to improve their delivery and bioavailability to the body. This paper highlights how novel techniques have achieved products with greater commercial viability and efficacy than their conventional counterparts. Importance of multicomponent products where individual bioactives potency is not subdued by each other has been marked. Ultimately it is the adoption and merging of the different formulation technologies and prudent scientific validation that will dictate the future success of nutraceuticals. This is especially pertinent in a market where an informed consumer demands an innovative all-in-one product that does not compromise in its results.
    Journal of Functional Foods 01/2014; 6(1):82-99. DOI:10.1016/j.jff.2013.09.022 · 4.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Polymer rheological property is one of intrinsic properties for the design and preparation of intravitreal injection systems. Rheological behaviors of thermosensitive poly(lactic acid‐co‐glycolic acid)‐poly(ethylene glycol)‐poly(lactic acid‐co‐glycolic acid) (PLGA‐PEG‐PLGA) triblock copolymers were investigated in this article. The rigidity phase angle (δ), elastic modulus (G′), viscous modulus (G″), and complex viscosity (η*) were determined. The injectability of polymers was evaluated as well. The results indicated both temperature and concentration were key parameters influencing elasticity of polymers. Owing to low complex viscosity (below 1 Pa s), PLGA‐PEG‐PLGA polymers can be successfully injected at room temperature. When the temperature was raised to 37°C, the complex viscosity increased (over 4 Pa s). Thus, suitable rheological properties (G′ > G″; tan δ G′), viscous modulus (G″), and complex viscosity (η*) were diminished when polymer solutions were ejected through syringe needles (25 gauge, G). Ejection force (from 4.21 to 19.42 N) was required in the process of injecting administration through syringe needles (24, 25, and 26 G) for polymer solutions at 20, 25, and 30% (w/v) concentration. © 2011 Wiley Periodicals, Inc. J Appl Polym Sci, 2012
    Journal of Applied Polymer Science 07/2012; 125(1). DOI:10.1002/app.35584 · 1.64 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Drug release from poly(lactide-co-glycolide) (PLGA) microspheres is strongly determined by the pore structure of the particles. This study examines how swelling-induced pore constriction delays the drug release and by which factors this process is controlled. Combination of different porosimetric and pycnometric methods enabled insight into the submicroscopic range of the pore structure and revealed that remarkably the polymer free volume plays a crucial role in drug release from PLGA microspheres. Surprisingly, the latter was shown to be inversely correlated to the degree of diffusional drug release. This can be explained by a swelling-induced constriction of the macroporous channel system in the microspheres which is related to the availability of free volume. The hole free volume was shown to be well controllable by the manufacturing conditions. Thus, the study deepens comprehension of the mechanism of drug release from biodegradable microparticles and offers an effective approach for controlling the release behavior. © 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 39740.
    Journal of Applied Polymer Science 01/2014; 131(1). DOI:10.1002/app.39740 · 1.40 Impact Factor